Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × chiauranib × Thoracic × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Blood Specimen Collection 41 Radiosurgery 35 Standard of Care 27 Early Intervention, Educational 27 Methods 25 Educational Status 25 Drug Therapy 24 Magnetic Resonance Spectroscopy 23 Exercise 21 Practice Guidelines as Topic 20 Radiotherapy 19 X-Rays 17 Surveys and Questionnaires 16 Biopsy 15 Tomography, X-Ray Computed 14 Carboplatin 14 Pemetrexed 13 Thoracic Surgery, Video-Assisted 12 Therapeutics 11 Interviews as Topic 10 Gefitinib 10 Surgical Procedures, Operative 9 Specimen Handling 9 Patient Navigation 9 Immunotherapy 9 Fluorodeoxyglucose F18 9 Cryosurgery 9 Cisplatin 9 anlotinib 8 Palliative Care 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05371899 2024-07-15

Mass Balance Study of [14C]Chiauranib

Chipscreen Biosciences, Ltd.

Phase NA Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡